Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is buying MicroDose Therapeutx for as much as $165 million.

MicroDose, headquartered in Monmouth Junction, N.J., develops inhalation technologies and products for lung diseases and infections. Terms of the deal were not disclosed.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.